FEMHRT Side Effects

6937644-9 | Abdominal Pain Upper, Back Pain, Breast Mass, Breast Pain, Breast Tenderness, Cholelithiasis, Nausea
on Aug 20, 2010 Female patient from UNITED STATES , weighting 136.2 lb, was diagnosed with migraine (What is migraine?) and was treated with Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, back pain (What is back pain?), breast mass, breast pain, breast tenderness, cholelithiasis, nausea (What is nausea?). Femhrt dosage: One Tablet (28 Total) Daily Orally.

6516776-3 | Breast Cancer
Patient was taking Femhrt (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Mar 16, 2009 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 229.9 lb, was diagnosed with menopausal symptoms and. Femhrt dosage: . During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), CRESTOR (View Crestor Review and Crestor Label ), NORVASC /00972401/ (AMLODIPINE) (View Norvasc /00972401/ (amlodipine) Review and Norvasc /00972401/ (amlodipine) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6516775-1 | Breast Cancer
Adverse event was reported on Mar 16, 2009 by a Female patient taking Femhrt (View Usage) (Dosage: ) . Location: UNITED STATES , 59 years of age, weighting 130.1 lb, After Femhrt was administered, patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), PREMPRO (View Prempro Review and Prempro Label ), NECROCIDE (View Necrocide Review and Necrocide Label ).

6516737-4 | Breast Cancer Female
on Mar 16, 2009 Female patient from UNITED STATES , 60 years of age, weighting 110.0 lb, was treated with Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer female. Femhrt dosage: Oral. During the same period patient was treated with PREMARIN (0.625 Mg, Oral) (View Premarin Review and Premarin Label ), PROVERA (5 Mg, Oral) (View Provera Review and Provera Label ), PREMPRO (6.25mg, Oral) (View Prempro Review and Prempro Label ), ESTRACE (View Estrace Review and Estrace Label ), CARDIZEM (View Cardizem Review and Cardizem Label ).


6516736-2 | Alopecia, Myocardial Infarction
on Jan 12, 2009 Female patient from UNITED STATES , 63 years of age, weighting 160.1 lb, was diagnosed with hot flush and was treated with Femhrt (View Usage). Patient had the following side effects: alopecia, myocardial infarction. Femhrt dosage: 0.5 Mg/2.5 Mcg, Oral. During the same period patient was treated with METOPROLOL (METOPROLOL) (View Metoprolol (metoprolol) Review and Metoprolol (metoprolol) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LIPITOR (View Lipitor Review and Lipitor Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6513215-3 | Breast Cancer
Patient was taking Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: breast cancer (What is breast cancer?) on Oct 24, 2008 from UNITED STATES Additional patient health information: Female patient , 57 years of age, . Femhrt dosage: . During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ).

6513212-8 | Breast Cancer
Adverse event was reported on Oct 24, 2008 by a Female patient taking Femhrt (View Usage) (Dosage: ) . Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), ESTRATEST (View Estratest Review and Estratest Label ).

6513208-6 | Breast Cancer
on Oct 24, 2008 Female patient from UNITED STATES , 60 years of age, was treated with Femhrt (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Femhrt dosage: . During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), ESTRATEST H.S. (View Estratest H.s. Review and Estratest H.s. Label ), PREMPHASE (PREMARIN;CYCRIN 14/14) (View Premphase (premarin;cycrin 14/14) Review and Premphase (premarin;cycrin 14/14) Label ), PROVERA (View Provera Review and Provera Label ), PREMPRO (View Prempro Review and Prempro Label ).

6513205-0 | Breast Cancer
on Oct 24, 2008 Female patient from UNITED STATES , 60 years of age, was treated with Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: breast cancer (What is breast cancer?). Femhrt dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), PREMPRO (View Prempro Review and Prempro Label ).

6259342-X | Condition Aggravated, Vulval Cancer, Vulvovaginal Mycotic Infection
Patient was taking Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, vulval cancer, vulvovaginal mycotic infection on Jun 23, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with pruritus and. Femhrt dosage: ,% Qd, Oral. During the same period patient was treated with PREMARIN (42.5 G, Qd, Vaginal) (View Premarin Review and Premarin Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), BUSPAR (View Buspar Review and Buspar Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (HYDROCODONE BITARTRATE, PARACETAMOL) (View Hydrochlorothiazide (hydrocodone Bitartrate, Paracetamol) Review and Hydrochlorothiazide (hydrocodone Bitartrate, Paracetamol) Label ), ZOCOR (View Zocor Review and Zocor Label ), LORTAB (View Lortab Review and Lortab Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized and became disabled.

6233417-3 | Asthenia, Depression, Fatigue, Mood Swings, Suicidal Ideation
Adverse event was reported on Jun 16, 2009 by a Female patient taking Femhrt (View Usage) (Dosage: 0.5 Mg Daily Po) was diagnosed with hot flush, menopause (What is menopause?), night sweats and. Location: UNITED STATES , 49 years of age, weighting 142.0 lb, Patient had the following side effects: asthenia, depression (What is depression?), fatigue, mood swings, suicidal ideation.

6106704-7 | Intestinal Resection, Pain In Extremity, Venous Thrombosis Limb
on Feb 23, 2009 Female patient from UNITED STATES , 54 years of age, weighting 147.9 lb, was diagnosed with menopausal symptoms and was treated with Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: intestinal resection, pain in extremity, venous thrombosis limb. Femhrt dosage: 1mg/5mcg, Qd, Oral. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SINGULAIR (View Singulair Review and Singulair Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), VYTORIN (View Vytorin Review and Vytorin Label ), NEXIUM (View Nexium Review and Nexium Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6034895-5 | Back Pain, Dizziness Postural, Menorrhagia, Sleep Disorder
on Jan 08, 2009 Female patient from UNITED STATES , 44 years of age, weighting 155.0 lb, was diagnosed with postmenopause and was treated with Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), dizziness postural, menorrhagia, sleep disorder (What is sleep disorder?). Femhrt dosage: 2 Pills Daily Po.

6000552-4 | Breast Cancer
Patient was taking Femhrt (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Apr 29, 2008 from UNITED STATES Additional patient health information: Female patient , 57 years of age, . Femhrt dosage: 5/1000 Ug, Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), ESTRATEST (View Estratest Review and Estratest Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMPHASE (PREMARIN;CYCRIN 14/14) (View Premphase (premarin;cycrin 14/14) Review and Premphase (premarin;cycrin 14/14) Label ).

5901529-7 | Pulmonary Embolism
Adverse event was reported on Sep 26, 2008 by a Female patient taking Femhrt (View Usage) (Dosage: 1 Tablet Daily 21days Oral Long Time) . Location: UNITED STATES , 70 years of age, weighting 185.6 lb, After Femhrt was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Patient was hospitalized.

5876350-9 | Feeling Abnormal, Loss Of Consciousness
on Aug 25, 2008 Female patient from UNITED STATES , 48 years of age, weighting 125.0 lb, was diagnosed with insomnia and was treated with Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: feeling abnormal, loss of consciousness. Femhrt dosage: 0.5mg/2.5mcg, Qd, Oral. During the same period patient was treated with AMBIEN (10 Mg, Prn, Oral) (View Ambien Review and Ambien Label ).

5607799-7 | Dizziness, Fall
on Jan 28, 2008 Female patient from UNITED STATES , 49 years of age, weighting 157.0 lb, was diagnosed with menopausal symptoms and was treated with Femhrt (View Usage). Patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?). Femhrt dosage: 1 Tablet Per Day Po.

5528720-6 | Breast Neoplasm
Patient was taking Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: breast neoplasm on Jul 26, 2007 from UNITED STATES Additional patient health information: Female patient , 57 years of age, . Femhrt dosage: 1mg/5mcg, Qd, Oral. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), BENICAR (View Benicar Review and Benicar Label ).

5421704-8 | Pulmonary Embolism
Adverse event was reported on Mar 01, 2007 by a Female patient taking Femhrt (View Usage) (Dosage: 1 Mg/5mcg, Qd, Oral) was diagnosed with atrophic vulvovaginitis, vaginal pain and. Location: UNITED STATES , 77 years of age, weighting 166.0 lb, Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with SEROQUEL /012709001/(UETIAPINE), 125 MG (View Seroquel /012709001/(uetiapine), 125 Mg Review and Seroquel /012709001/(uetiapine), 125 Mg Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PEPCID /00706001(FAMOTIDINE) (View Pepcid /00706001(famotidine) Review and Pepcid /00706001(famotidine) Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

5421678-X | Cholelithiasis, Pulmonary Embolism
on Mar 01, 2007 Female patient from UNITED STATES , 48 years of age, weighting 229.9 lb, was diagnosed with menopausal symptoms and was treated with Femhrt (View Usage). Patient had the following side effects: cholelithiasis, pulmonary embolism (What is pulmonary embolism?). Femhrt dosage: 1mg/5cmg, Qd, Oral, 5/1000 Ug. During the same period patient was treated with MULTIVITAMINS (ASCORBIC ACID, ERGOCALCIFEROL, FOLIC ACID, NOCOTINAMIDE (View Multivitamins (ascorbic Acid, Ergocalciferol, Folic Acid, Nocotinamide Review and Multivitamins (ascorbic Acid, Ergocalciferol, Folic Acid, Nocotinamide Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

5421677-8 | Breast Cancer
on Oct 30, 2006 Female patient from UNITED STATES , 55 years of age, was treated with Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: breast cancer (What is breast cancer?). Femhrt dosage: . During the same period patient was treated with ESTRACE (View Estrace Review and Estrace Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ).

5421666-3 | Breast Cancer
Patient was taking Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?) on Oct 30, 2006 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with menopausal symptoms and. Femhrt dosage: . During the same period patient was treated with ESTRACE (View Estrace Review and Estrace Label ), PROVERA (View Provera Review and Provera Label ), PREMPRO (View Prempro Review and Prempro Label ).

5421664-X | Breast Cancer
Adverse event was reported on Sep 05, 2006 by a Female patient taking Femhrt (View Usage) (Dosage: Oral) was diagnosed with menopausal symptoms and. Location: UNITED STATES , 72 years of age, Patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMARIN (Oral) (View Premarin Review and Premarin Label ), PROVERA (Oral) (View Provera Review and Provera Label ), PREMPRO (Oral) (View Prempro Review and Prempro Label ).

5421662-6 | Breast Cancer, Metrorrhagia
on Aug 24, 2006 Female patient from UNITED STATES , 62 years of age, weighting 140.0 lb, was diagnosed with menopausal symptoms and was treated with Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: breast cancer (What is breast cancer?), metrorrhagia. Femhrt dosage: 1 Mg/5 Mcg, Qd, Oral. During the same period patient was treated with PREMARIN (Oral) (View Premarin Review and Premarin Label ), CELEBREX (View Celebrex Review and Celebrex Label ), TRAM/ATAP (View Tram/atap Review and Tram/atap Label ).

5421647-X | Breast Cancer
on Jun 14, 2006 Female patient from UNITED STATES , 58 years of age, was treated with Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Femhrt dosage: 1mg/5 Mcg, Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ), PREMPRO (View Prempro Review and Prempro Label ).

5421620-1 | Breast Cancer
Patient was taking Femhrt (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Jun 13, 2006 from UNITED STATES Additional patient health information: Female patient , 56 years of age, . Femhrt dosage: 1 Mg/5 Mcg, Oral. During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ).

5413152-1 | Abscess Limb, Amnesia, Back Pain, Cerebrovascular Accident, Confusional State, Convulsion, Dizziness, Fatigue, Loss Of Consciousness
Adverse event was reported on Jul 26, 2007 by a Female patient taking Femhrt (View Usage) (Dosage: 0.5mg/2.5mcg, Qd, Oral) was diagnosed with abscess limb and. Location: UNITED STATES , 51 years of age, weighting 149.9 lb, After Femhrt was administered, patient had the following side effects: abscess limb, amnesia, back pain (What is back pain?), cerebrovascular accident, confusional state, convulsion, dizziness (What is dizziness?), fatigue, loss of consciousness. During the same period patient was treated with OMNICEF /01130201/(CEFDINIR) CAPSULE, 300MG (300 Mg, Oral) (View Omnicef /01130201/(cefdinir) Capsule, 300mg Review and Omnicef /01130201/(cefdinir) Capsule, 300mg Label ), AMBIEN (View Ambien Review and Ambien Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ), FISH OIL (FISH OIL) TABLET (View Fish Oil (fish Oil) Tablet Review and Fish Oil (fish Oil) Tablet Label ), VITAMIN B12 (View Vitamin B12 Review and Vitamin B12 Label ). Patient was hospitalized.

5306921-X | Tendonitis
on Apr 10, 2007 Female patient from UNITED STATES , 50 years of age, weighting 149.9 lb, was diagnosed with contraception and was treated with Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: tendonitis. Femhrt dosage: 1.0mg/5mcg, Qd, Oral.

5247220-4 | Anxiety, Blood Pressure Increased, Feeling Hot, Hypoaesthesia, Malaise, Palpitations
on Feb 05, 2007 Female patient from UNITED STATES , 50 years of age, weighting 151.0 lb, was diagnosed with menopausal symptoms and was treated with Femhrt (View Usage). Patient had the following side effects: anxiety (What is anxiety?), blood pressure increased, feeling hot, hypoaesthesia, malaise, palpitations. Femhrt dosage: 1 Mg/5mcg, Qd, Oral. During the same period patient was treated with ALLEGRA /01314201/ (FEXOFENADINE) (View Allegra /01314201/ (fexofenadine) Review and Allegra /01314201/ (fexofenadine) Label ), NEXIUM /01479302/ (ESOMEPRAZOLE MAGNESIUM) (View Nexium /01479302/ (esomeprazole Magnesium) Review and Nexium /01479302/ (esomeprazole Magnesium) Label ). Patient was hospitalized.

5196773-3 | Breast Cancer Female
Patient was taking Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: breast cancer female on Dec 29, 2006 from UNITED STATES Additional patient health information: Female patient , 42 years of age, weighting 175.0 lb, . Femhrt dosage: 1 Pill Daily.

5123035-2 | Condition Aggravated, Economic Problem, Grand Mal Convulsion, Multiple Sclerosis
Adverse event was reported on Sep 26, 2006 by a Female patient taking Femhrt (View Usage) (Dosage: 5/1000ug, Qd, Oral) was diagnosed with hot flush, depression (What is depression?) and. Location: UNITED STATES , 45 years of age, weighting 170.0 lb, Patient experienced the following unwanted or unexpected effects: condition aggravated, economic problem, grand mal convulsion, multiple sclerosis (What is multiple sclerosis?). During the same period patient was treated with EFFEXOR (Und, Qd, Oral) (View Effexor Review and Effexor Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5119462-X | Condition Aggravated, Depression, Economic Problem, Grand Mal Convulsion, Multiple Sclerosis
on Sep 13, 2006 Female patient from UNITED STATES , 45 years of age, weighting 170.0 lb, was diagnosed with hot flush, depression (What is depression?) and was treated with Femhrt (View Usage). Patient had the following side effects: condition aggravated, depression (What is depression?), economic problem, grand mal convulsion, multiple sclerosis (What is multiple sclerosis?). Femhrt dosage: 5/1000ug, Qd Oral. During the same period patient was treated with EFFEXOR (Qd Oral) (View Effexor Review and Effexor Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5109328-3 | Abdominal Pain, Dyspnoea, Fatigue, Genital Tract Inflammation, Oedema Peripheral, Pain In Extremity, Purulent Discharge, Vomiting
on Sep 01, 2006 Female patient from UNITED STATES , 61 years of age, was treated with Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), dyspnoea, fatigue, genital tract inflammation, oedema peripheral, pain in extremity, purulent discharge, vomiting. Femhrt dosage: 5/1000 Ug, Qd, Oral. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), ADVIL COLD AND SINUS (View Advil Cold And Sinus Review and Advil Cold And Sinus Label ). Patient was hospitalized.

5078220-5 | Blood Pressure Fluctuation, Chest Discomfort
Patient was taking Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure fluctuation, chest discomfort on Jul 30, 2005 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 379.2 lb, was diagnosed with menopausal symptoms and. Femhrt dosage: 5/1000 Ug Qd, Oral. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

5078217-5 | Breast Cancer
Adverse event was reported on Jul 26, 2005 by a Female patient taking Femhrt (View Usage) (Dosage: Oral) was diagnosed with menopausal symptoms and. Location: UNITED STATES , 65 years of age, Patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMPRO (Oral) (View Prempro Review and Prempro Label ).

5078195-9 | Breast Cancer, Breast Cancer In Situ
on May 26, 2005 Female patient from UNITED STATES , 66 years of age, was diagnosed with menopausal symptoms and was treated with Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: breast cancer (What is breast cancer?), breast cancer in situ. Femhrt dosage: Oral. During the same period patient was treated with PREMARIN (Oral) (View Premarin Review and Premarin Label ), PROVERA (Oral) (View Provera Review and Provera Label ), PREMPRO (Oral) (View Prempro Review and Prempro Label ). Patient was hospitalized.

5077908-X | Breast Cancer
on May 23, 2006 Female patient from UNITED STATES , 59 years of age, was treated with Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Femhrt dosage: 5/1000 Ug, Oral. During the same period patient was treated with ESTRACE (View Estrace Review and Estrace Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), ESTRATEST (View Estratest Review and Estratest Label ), AYGESTIN (View Aygestin Review and Aygestin Label ), PROVERA (View Provera Review and Provera Label ).

5077907-8 | Breast Cancer
Patient was taking Femhrt (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on May 23, 2006 from UNITED STATES Additional patient health information: Female patient , 56 years of age, . Femhrt dosage: 5/1000 Ug, Oral. During the same period patient was treated with MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), PREMPRO (View Prempro Review and Prempro Label ), ESTRATEST (View Estratest Review and Estratest Label ), PROVERA (View Provera Review and Provera Label ), COMBIPATCH (View Combipatch Review and Combipatch Label ), ESTRACE (View Estrace Review and Estrace Label ).

5077906-6 | Breast Cancer
Adverse event was reported on May 01, 2006 by a Female patient taking Femhrt (View Usage) (Dosage: 5/1000 Ug, Oral) . Location: UNITED STATES , 57 years of age, After Femhrt was administered, patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), ESTRATEST (View Estratest Review and Estratest Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMPHASE (PREMARIN;CYCRIN 14/14) (View Premphase (premarin;cycrin 14/14) Review and Premphase (premarin;cycrin 14/14) Label ).

5077904-2 | Breast Cancer In Situ
on Apr 04, 2006 Female patient from UNITED STATES , 63 years of age, was diagnosed with menopausal symptoms and was treated with Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer in situ. Femhrt dosage: 5/1000 Ug. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), PREMPRO (View Prempro Review and Prempro Label ).

5077903-0 | Breast Cancer
on Apr 05, 2006 Female patient from UNITED STATES , 57 years of age, was diagnosed with menopausal symptoms and was treated with Femhrt (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Femhrt dosage: 5/1000. During the same period patient was treated with COMBIPATCH (View Combipatch Review and Combipatch Label ), ESTRATAB (View Estratab Review and Estratab Label ).

5077902-9 | Breast Cancer, Breast Cancer In Situ
Patient was taking Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: breast cancer (What is breast cancer?), breast cancer in situ on Apr 05, 2006 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with menopausal symptoms and. Femhrt dosage: 5/1000 Ug. During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ), PROVERA (View Provera Review and Provera Label ), PREMARIN (View Premarin Review and Premarin Label ).

5077901-7 | Breast Cancer
Adverse event was reported on Mar 30, 2006 by a Female patient taking Femhrt (View Usage) (Dosage: 5/1000ug, Oral) . Location: UNITED STATES , 74 years of age, Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMARIN (Oral) (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), AYGESTIN (View Aygestin Review and Aygestin Label ), PREMPRO (View Prempro Review and Prempro Label ).

5077716-X | Breast Cancer
on Mar 21, 2006 Female patient from UNITED STATES , 60 years of age, was treated with Femhrt (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Femhrt dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMPHASE (PREMARIN;CYCRIN 14/14) (View Premphase (premarin;cycrin 14/14) Review and Premphase (premarin;cycrin 14/14) Label ).

5077713-4 | Breast Cancer
on Feb 27, 2006 Female patient from UNITED STATES , 57 years of age, was treated with Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: breast cancer (What is breast cancer?). Femhrt dosage: 5/1000ug Qd, Oral.

5077708-0 | Breast Cancer
Patient was taking Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?) on Dec 28, 2005 from UNITED STATES Additional patient health information: Female patient , 53 years of age, . Femhrt dosage: 5/1000 Ug, Oral. During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ), ESTRATEST (View Estratest Review and Estratest Label ), ORTHO EST (View Ortho-est Review and Ortho-est Label ), MENEST (View Menest Review and Menest Label ).

5077706-7 | Breast Cancer
Adverse event was reported on Aug 23, 2005 by a Female patient taking Femhrt (View Usage) (Dosage: 5/1000 Ug Qd, Oral) . Location: UNITED STATES , 54 years of age, Patient had the following side effects: breast cancer (What is breast cancer?).

5077705-5 | Breast Cancer
on Nov 28, 2005 Female patient from UNITED STATES , 58 years of age, was treated with Femhrt (View Usage). After Femhrt was administered, patient had the following side effects: breast cancer (What is breast cancer?). Femhrt dosage: Oral. During the same period patient was treated with PREMPRO (Oral) (View Prempro Review and Prempro Label ).

4923862-8 | Deep Vein Thrombosis
on Feb 24, 2006 Female patient from UNITED STATES , 54 years of age, weighting 165.3 lb, was diagnosed with menopause (What is menopause?) and was treated with Femhrt (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). Femhrt dosage: 1 Qday Po. Patient was hospitalized and became disabled.

4732039-0 | Cerebrovascular Accident
Patient was taking Femhrt (View Usage). Patient had the following side effects: cerebrovascular accident on Apr 14, 2005 from UNITED STATES Additional patient health information: Female patient , 57 years of age, . Femhrt dosage: Oral. Patient was hospitalized.